Perturbation of ATP-induced tetramerization of human cytosolic thymidine kinase by substitution of serine-13 with aspartic acid at the mitotic phosphorylation site

Biochemical and Biophysical Research Communications

Volumn 313, Issue 3, 2004, Pages 587-593

  Li, Chia Lung ^a   Lu, Ching Yi ^a   Ke, Po Yuan ^a   Chang, Zee Fen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cell cycle; Kinetics; Oligomerization; Phosphorylation; Thymidine kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASPARTIC ACID; SERINE DERIVATIVE; TETRAMER; THYMIDINE KINASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; GENE MUTATION; MITOSIS RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBSTITUTION REACTION;

EID: 0347694727     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.147     Document Type: Article

References (29)

1. Bello L.J. Regulation of thymidine kinase synthesis in human cells. Exp. Cell Res. 89:1974;263-274.
2. Johnson L.F., Rao L.G., Muench A.J. Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroblasts. Exp. Cell Res. 138:1982;79-85.
3. Adler R., McAuslan B.R. Expression of thymidine kinase variants is a function of the replicative state of cells. Cell. 2:1974;113-117.
4. Munch-Petersen B., Tyrsted G. Induction of thymidine kinases in phytohaemagglutinin-stimulated human lymphocytes. Biochim. Biophys. Acta. 478:1977;364-375.
5. Stuart P., Ito M., Stewart C., Conrad S.E. Induction of cellular thymidine kinase occurs at the mRNA level. Mol. Cell. Biol. 5:1985;1490-1497.
6. Coppock D.L., Pardee A.B. Control of thymidine kinase mRNA during the cell cycle. Mol. Cell. Biol. 7:1987;2925-2932.
7. Roehl H.H., Conrad S.E. Identification of a G1-S-phase-regulated region in the human thymidine kinase gene promoter. Mol. Cell. Biol. 10:1990;3834-3837.
8. Lipson K.E., Chen S.T., Koniecki J., Ku D.H., Baserga R. S-phase-specific regulation by deletion mutants of the human thymidine kinase promoter. Proc. Natl. Acad. Sci. USA. 86:1989;6848-6852.
9. Kim Y.K., Lee A.S. Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors. Mol. Cell. Biol. 11:1991;2296-2302.
10. Sherley J.L., Kelly T.J. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem. 263:1988;8350-8358.
11. Ito M., Conrad S.E. Independent regulation of thymidine kinase mRNA and enzyme levels in serum-stimulated cells. J. Biol. Chem. 265:1990;6954-6960.
12. Kauffman M.G., Kelly T.J. Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol. Cell. Biol. 11:1991;2538-2546.
13. Sutterluety H., Bartl S., Karlseder J., Wintersberger E., Seiser C. Carboxy-terminal residues of mouse thymidine kinase are essential for rapid degradation in quiescent cells. J. Mol. Biol. 259:1996;383-392.
14. Munch-Petersen B., Tyrsted G., Cloos L. Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties. J. Biol. Chem. 268:1993;15621-15625.
15. Munch-Petersen B., Cloos L., Jensen H.K., Tyrsted G. Human thymidine kinase 1. Regulation in normal and malignant cells. Adv. Enzyme Regul. 35:1995;69-89.
16. Chang Z.F., Huang D.Y. The regulation of thymidine kinase in HL-60 human promyeloleukemia cells. J. Biol. Chem. 268:1993;1266-1271.
17. He Q., Skog S., Wu C., Johansson A., Tribukait B. Existence of phosphorylated and dephosphorylated forms of cytosolic thymidine kinase (TK1). Biochim. Biophys. Acta. 1289:1996;25-30.
18. Chang Z.F., Huang D.Y., Hsue N.C. Differential phosphorylation of human thymidine kinase in proliferating and M phase-arrested human cells. J. Biol. Chem. 269:1994;21249-21254.
19. Chang Z.F., Huang D.Y., Chi L.M. Serine 13 is the site of mitotic phosphorylation of human thymidine kinase. J. Biol. Chem. 273:1998;12095-12100.
20. Berenstein D., Christensen J.F., Kristensen T., Hofbauer R., Munch-Petersen B. Valine, not methionine, is amino acid 106 in human cytosolic thymidine kinase (TK1). Impact on oligomerization, stability, and kinetic properties. J. Biol. Chem. 275:2000;32187-32192.
21. Ke P.Y., Yang C.C., Tsai I.C., Chang Z.F. Degradation of human thymidine kinase is dependent on serine-13 phosphorylation: involvement of the SCF-mediated pathway. Biochem. J. 370:2003;265-273.
22. ′ -untranslated region of human thymidine kinase mRNA Biochim. Biophys. Acta. 1519:2001;209-215.
23. Munch-Petersen B. Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes. Mol. Cell. Biochem. 64:1984;173-185.
24. Munch-Petersen B., Cloos L., Tyrsted G., Eriksson S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem. 266:1991;9032-9038.
25. Posch M., Hauser C., Seiser C. Substrate binding is a prerequisite for stabilisation of mouse thymidine kinase in proliferating fibroblasts. J. Mol. Biol. 300:2000;493-502.
26. Bradshaw H.D. Jr., Deininger P.L. Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol. Cell. Biol. 4:1984;2316-2320.
27. Holden L., Hoffbrand A.V., Tattersall M.H. Thymidine concentrations in human sera: variations in patients with leukaemia and megaloblastic anaemia. Eur. J. Cancer. 16:1980;115-121.
28. Ferraro P., Bianchi V., Biasin M.R., Celotti L. Deoxynucleotide pools and DNA synthesis in resting and PHA-stimulated human lymphocytes treated with mutagens. Exp. Cell Res. 199:1992;349-354.
29. P.Y. Ke, Z.F. Chang, Mitotic degradation of human thymidine kinase 1 is dependent on APC/Cdh1 pathway, Mol. Cell. Biol. 24 (2004), in press.